Seek urgent medical attention if you experience: Persistent high blood glucose readings (above 15 mmol/L) Symptoms of hyperglycaemia that don't improve with treatment Unexplained weight loss or persistent fatigue Diabetic ketoacidosis (DKA) is uncommon in type 2 diabetes but can occur in certain situations, particularly if you have significant insulin deficiency, are taking SGLT2 inhibitors, or have a serious illness
To combat potential gastrointestinal adverse effects, physicians should prescribe a lower dose initially and titrate slowly or use the extended-release formulation to improve tolerance
AIt is generally administered by a qualified healthcare professional
doi:10.1016/j.jdiacomp.2020.107733 A Review of Diabetic Gastroparesis for the Community Pharmacist
That is, compared to placebo (non-use) or active comparators (i.e., metformin, TZD, and insulin), use of SGLT2is significantly decreased visceral adipose tissue volume and liver enzymes (i.e., alanine aminotransferase [ALT], aspartate aminotransferase [AST])